Cargando…

Editorial: Interaction Between Modern Radiotherapy and Novel Drugs in Prostate Cancer: Future Perspectives

Detalles Bibliográficos
Autores principales:	Detti, Beatrice, Zilli, Thomas, Ingrosso, Gianluca, Ribeiro, Ivone, Lancia, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005631/ https://www.ncbi.nlm.nih.gov/pubmed/35433471 http://dx.doi.org/10.3389/fonc.2022.876318

Ejemplares similares

Editorial: Controversies and Perspectives in the Use of Postoperative Radiotherapy for Prostate Cancer
por: Dal Pra, Alan, et al.
Publicado: (2017)

Editorial: Reviews in genitourinary oncology
por: Arcangeli, Stefano, et al.
Publicado: (2023)

Interaction Between Modern Radiotherapy and Immunotherapy for Metastatic Prostate Cancer
por: Ollivier, Luc, et al.
Publicado: (2021)

Management of prostate cancer radiotherapy during the COVID-19 pandemic: A necessary paradigm change
por: Detti, Beatrice, et al.
Publicado: (2021)

Editorial: Implementation of novel drugs and modern radiotherapy in the treatment of lymphoma patients
por: Levis, Mario, et al.
Publicado: (2023)

Editorial: Advances in radiotherapy for prostate cancer
por: Kamran, Sophia C., et al.
Publicado: (2022)

Choline PET/CT in recurrent prostate cancer
por: Detti, Beatrice, et al.
Publicado: (2023)

Editorial: Stereotactic body radiotherapy for prostate cancer
por: Kishan, Amar U., et al.
Publicado: (2022)

PET/CT-Based Salvage Radiotherapy for Recurrent Prostate Cancer After Radical Prostatectomy: Impact on Treatment Management and Future Directions
por: le Guevelou, Jennifer, et al.
Publicado: (2021)

Drug Intensification in Future Postoperative Radiotherapy Practice in Biochemically-Relapsing Prostate Cancer Patients
por: Cailleteau, Axel, et al.
Publicado: (2021)

Personalization in Modern Radiation Oncology: Methods, Results and Pitfalls. Personalized Interventions and Breast Cancer
por: Aristei, Cynthia, et al.
Publicado: (2021)

The Risk of Second Primary Cancers in Prostate Cancer Survivors Treated in the Modern Radiotherapy Era
por: Jahreiß, Marie-Christina, et al.
Publicado: (2020)

Editorial: Clinical Application of Stereotactic Body Radiotherapy (SBRT): Cranium to Prostate
por: Vargo, John A., et al.
Publicado: (2015)

Editorial: CRISPR advancement in cancer research and future perspectives
por: Biagioni, Alessio, et al.
Publicado: (2023)

Target Definition in Salvage Radiotherapy for Recurrent Prostate Cancer: The Role of Advanced Molecular Imaging
por: Amzalag, Gaël, et al.
Publicado: (2016)

Editorial: Future Perspectives of Sentinel Node Mapping in Gynecological Oncology
por: Santoro, Angela, et al.
Publicado: (2022)

Editorial: Image-Guided Radiotherapy for Effective Radiotherapy Delivery
por: Nguyen, Nam P., et al.
Publicado: (2015)

Modern Radiotherapy Concepts and the Impact of Radiation on Immune Activation
por: Deloch, Lisa, et al.
Publicado: (2016)

Local Dose Effects for Late Gastrointestinal Toxicity After Hypofractionated and Conventionally Fractionated Modern Radiotherapy for Prostate Cancer in the HYPRO Trial
por: Heemsbergen, Wilma D., et al.
Publicado: (2020)

Editorial: Intraoperative Ultrasound in Brain Tumor Surgery: State-Of-The-Art and Future Perspectives
por: Del Bene, Massimiliano, et al.
Publicado: (2021)

Editorial: The Evolving Landscape, Clinical Implications, and Future Perspective of Biomarkers in Gastrointestinal Cancers
por: Tsai, Hsiang-Lin, et al.
Publicado: (2022)

The sternum reconstruction: Present and future perspectives
por: Aramini, Beatrice, et al.
Publicado: (2022)

Editorial: Strengths and Challenges of Allo-SCT in the Modern Era
por: Malagola, Michele, et al.
Publicado: (2022)

FLASH Radiotherapy: History and Future
por: Lin, Binwei, et al.
Publicado: (2021)

Biomarkers to Evaluate Androgen Deprivation Therapy for Prostate Cancer and Risk of Alzheimer’s Disease and Neurodegeneration: Old Drugs, New Concerns
por: Achard, Vérane, et al.
Publicado: (2021)

Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study
por: Triggiani, Luca, et al.
Publicado: (2017)

The Interplay Between Prostate Cancer Genomics, Metabolism, and the Epigenome: Perspectives and Future Prospects
por: Singh, Reema, et al.
Publicado: (2021)

Editorial: New Approaches to Breast Cancer Radiotherapy
por: Jacobson, Geraldine Meerbott, et al.
Publicado: (2021)

Editorial: Online Adaptive MR-Guided Radiotherapy
por: Kerkmeijer, Linda G. W., et al.
Publicado: (2021)

Editorial: Impact of radiotherapy and radiosurgery on neuro-oncology
por: Conti, Alfredo
Publicado: (2022)

Editorial: Recent advances in cervical cancer radiotherapy
por: Varlotto, John Michael, et al.
Publicado: (2023)

Editorial: Recent developments in pancreatic cancer radiotherapy
por: Chow, James C. L., et al.
Publicado: (2023)

Editorial: Stereotactic body radiotherapy for lung cancer
por: Liu, An, et al.
Publicado: (2023)

Editorial: Modern neurosurgical management of gliomas, including local therapies
por: Spallone, Aldo
Publicado: (2023)

Accuracy and reliability of a commercial treatment planning system in nontarget regions in modern prostate radiotherapy
por: Danckaert, Willeke, et al.
Publicado: (2023)

Big Data Analytics for Prostate Radiotherapy
por: Coates, James, et al.
Publicado: (2016)

MR-Guided Radiotherapy for Prostate Cancer
por: Tocco, Boris R., et al.
Publicado: (2020)

Editorial: Epigenetics in prostate cancer
por: Baniahmad, Aria, et al.
Publicado: (2023)

Androgen Receptor Targeted Therapy + Radiotherapy in Metastatic Castration Resistant Prostate Cancer
por: Massaro, Maria, et al.
Publicado: (2021)

Secondary cancer risk from modern external-beam radiotherapy of prostate cancer patients: Impact of fractionation and dose distribution
por: Sitathanee, Chomporn, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ddgpijqq7qto187al8vlumg392